Skip to main content
Premium Trial:

Request an Annual Quote

Bravo! ... But We're Still Counting on That Veto

Last week, the director of the National Institute of Neurological Disorders and Stroke at the NIH told Congress that the US government's limits on stem cell research mean that scientists are "missing out on possible breakthroughs." Story Landis, NINDS director, was asked by Sen. Edward Kennedy (D-Mass.) to tell the Senate what impact President George W. Bush's funding restrictions have had, according to this article from Yahoo! News.

The Senate is slated to vote on the bill soon, and if it is passed it is widely expected to be vetoed for a second time by Bush.

 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.